Skip to main
BLLN

Billiontoone Inc (BLLN) Stock Forecast & Price Target

Billiontoone Inc (BLLN) Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 43%
Buy 29%
Hold 29%
Sell 0%
Strong Sell 0%

Bulls say

BillionToOne Inc has demonstrated impressive financial performance, with gross margins rising significantly to 53.0% in 2024 from 24.1% due to operational scaling, highlighting effective management of costs alongside revenue growth. The company has reported exceptional year-over-year revenue increases, such as a 102% surge in prenatal test revenue and a staggering 664% growth in oncology revenue, setting the stage for a potential revenue compound annual growth rate (CAGR) exceeding 25% in the reproductive health sector. Furthermore, BillionToOne achieved its first positive net income of $1.5 million, combined with a steady increase in tests per patient, indicating substantial opportunities for future growth and market share acquisition.

Bears say

BillionToOne Inc faces significant challenges that may negatively impact its financial outlook, particularly concerning the protection of its proprietary technology, which could weaken its competitive position. The company is also at risk of reduced revenue due to potential reimbursement decreases under the Medicare program and state Medicaid programs, compounded by increasing denial rates from payers regarding the efficacy of its tests. Moreover, slower-than-anticipated revenue growth from its foundational prenatal testing business and newer oncology tests, alongside potential delays in successful pipeline initiatives, indicates that profitability may be further pressured in the coming periods.

Billiontoone Inc (BLLN) has been analyzed by 7 analysts, with a consensus rating of Buy. 43% of analysts recommend a Strong Buy, 29% recommend Buy, 29% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Billiontoone Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Billiontoone Inc (BLLN) Forecast

Analysts have given Billiontoone Inc (BLLN) a Buy based on their latest research and market trends.

According to 7 analysts, Billiontoone Inc (BLLN) has a Buy consensus rating as of Apr 8, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $126.71, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $126.71, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Billiontoone Inc (BLLN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.